Inventor
Michael ROSCONI
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,474,349Methods for characterizing protein complexes202512,391,753Antigen binding molecule formats202512,331,109Antigen binding molecule formats202512,215,148Antigen binding molecule formats202512,180,272Antigen binding molecule formats202411,965,020Antigen binding molecule formats202411,754,569Methods for characterizing protein complexes202311,708,407Antigen binding molecule formats2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to REGENERON PHARMA (8)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 8 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2023–2025 |